INM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
InMed Pharmaceuticals Inc (INM) is not a strong buy for a beginner, long-term investor at this time. The lack of significant positive catalysts, weak technical indicators, and no proprietary trading signals suggest holding off on investment until clearer opportunities emerge.
The MACD histogram is negative (-0.0401) and expanding, indicating bearish momentum. RSI is neutral at 44.076, and moving averages are converging, suggesting indecision in price movement. The stock is trading near its support level of 1.467, with resistance levels at 1.581 and 1.617.
NULL identified. No significant insider or hedge fund activity. No proprietary trading signals.
The merger with Mentari Therapeutics, Inc. dilutes InMed shareholders to only 1.51% ownership of the combined entity, which could negatively impact shareholder value. Technical indicators suggest bearish momentum.
No financial data available for analysis.
No recent analyst ratings or price target changes available.
